China Resources Boya Bio pharmaceutical Group Co Ltd SZSE:300294:
SAYS HUI REN RESIGNS AS PRESIDENT, DIRECTOR DUE TO JOB CHANGE
China Resources Pharmaceutical: Hui Ren Resigns As President Due To Job Change
Earlier from China Resources Boya Bio-pharmaceutical Group Co., Ltd. Class A
- China Resources Pharmaceutical Says 9M Net Profit For CR Boya Bio-Pharmaceutical At RMB343 Million
- China Resources Boya Bio-pharmaceutical Group: Revenue up, profit down YTD, cash flow pressured, Boya Xinhe deconsolidated
- China Resources Boya Bio-pharmaceutical Group: Revenue up 12.5% but net profit down 28.7% amid margin and policy pressures
- China Resources Boya Bio-pharmaceutical Group: Revenue up 19.49% but net profit down 8.25% as costs rise and cash flow turns negative